The Science of ADHD (2ND)

個数:

The Science of ADHD (2ND)

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて

  • 提携先の海外書籍取次会社に在庫がございます。通常約2週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 544 p.
  • 言語 ENG
  • 商品コード 9781118941249
  • DDC分類 616.8589

Full Description

A comprehensive and evidence-based guide to understanding ADHD and its treatment

ADHD remains one of the most widely misunderstood neurodevelopmental disorders, with debates surrounding its diagnosis, causes, and treatment continuing to evolve. The Science of ADHD provides a clear, balanced, and up-to-date exploration of this complex condition. With an accessible narrative style, author Chris Chandler expertly navigates the latest research to present an objective look at ADHD's neuroscience, genetics, psychological theories, and treatment approaches.

The fully revised second edition reflects the latest advancements in the field, including updated diagnostic criteria and a nuanced discussion of ADHD as a neurodevelopmental disorder. New and expanded chapters address the impact of non-pharmacological treatments, ADHD's association with addiction, ongoing challenges in ADHD research, the broader implications of neurodiversity, and more. Throughout this edition, engaging discussions of genetics, neuroscience, and psychology enable readers to develop a deeper understanding of ADHD and its implications.

Empowering readers with the knowledge needed to make informed decisions, The Science of ADHD:



Discusses emerging research, treatment innovations, and ongoing questions in ADHD science
Balances academic depth with readability, making complex concepts approachable for non-specialists and professionals alike
Offers actionable insights for educators, clinicians, and parents to better support individuals with ADHD
Covers pharmacological, non-pharmacological, and emerging treatment options, alongside critiques of current approaches
Features real-life insights and experiences shared by individuals with ADHD and their family members
Includes a glossary and a well-organized layout to help readers navigate scientific terms and concepts effectively

Bridging the gap between cutting-edge science and everyday experience, The Science of ADHD, Second Edition, is ideal for undergraduate and postgraduate psychology and neuroscience courses focusing on developmental disorders or psychobiology. It is also a valuable reference for clinicians, educators, and policymakers seeking a research-backed understanding of ADHD to support individuals in diverse settings.

Contents

Preface to the Second Edition xv

Preface to the First Edition xvii

Acknowledgments xxi

1 What Is ADHD? 1

What Does ADHD Look Like and Who Has It? 2

ADHD - Two Faces of the Same Coin 3

The Negative Impact of ADHD 6

What Is ADHD Like? 6

Adult Male Personal Account A 11

Adult Female Personal Account 15

A Child's Personal Account (Diagnosed at the Age of 8 Years) 18

A Parent's View 19

Another Parent's View 22

A Mother with ADHD's Personal Account of Parenting a Daughter with ADHD 25

Are There Any Positive Aspects to Having ADHD? 28

ADHD: Science and Society 31

Science and Proof 32

Good Science and Drug Development 38

Summary 41

2 Diagnosis, Epidemiology, and Comorbidity 43

A Short History of ADHD 44

Formal Diagnosis 48

DSM Criteria 51

DSM vs. ICD 58

Is ADHD Real? 65

Adult ADHD 67

Is Adult ADHD Real? 69

Diagnosis and the Future Criteria 71

Assessment 71

Rating Scales 73

ADHD Rating Scales: Children 74

SNAP-IV, SKAMP, and SWAN 74

ADHD Rating Scale IV (ADHD RS IV) and ADHD RS 5 74

Conner's Rating Scales - Revised (CRS-R) 74

Vanderbilt ADHD Teacher and Parent Rating Scales (VADTRS and VANPRS) 75

ADHD Symptoms Rating Scale 75

Attention Deficit Disorder Evaluation Scale - Second Edition (addes 2) 75

ACTeRS - 2nd Edition 75

Brown Attention-Deficit Disorder Scales for Children and Adolescents (BADDS) 75

The Child Behavior Checklist (CBCL) 76

The Strengths and Difficulties Questionnaire (SDQ) 76

Parental Account of Childhood Symptoms (PACS) 76

Weiss Functional Impairment Rating Scale (WFIRS) 76

ADHD Rating Scales: Adults 76

Wender Utah Rating Scale (WURS) (See Also Adult ADHD) 77

Conner's Adult ADHD Rating Scales (CAARS) 77

Brown Adult ADD Scale 77

The Adult ADHD Self-Report Scale (ASRS) 77

Rating Scales: Summary 77

Epidemiology 78

The Cultural Context of Diagnosis 80

Sex Differences 81

Over- and Underdiagnosis 82

Prognosis 83

Comorbidity - Not Just ADHD 85

Autism and ADHD 87

Prevalence of ASD with and Without ADHD 88

Implications of ASD and ADHD 88

Summary 88

3 Causality and the Environmental Hypotheses of ADHD 91

What Causes ADHD? 91

Causality 92

Animal Models of ADHD 93

Genetic Models 96

Alpha-synuclein Lacking Mice 98

Physical Trauma/Environment 98

Anoxia/Hypoxia in Neonatal Rodents 99

X-radiation of Neonatal Rodents 99

Cerebellar Stunting Model of ADHD 99

Maternally Stressed Mice 99

Prenatal Ethanol Exposure 100

What Can Animal Models Tell Us About ADHD? 100

The Environment 100

The Environment in Utero: Pregnancy, Birth Complications, and Teratology 101

Pregnancy and Birth Complications 101

Teratology: Are Neurotoxins a Possible Cause? 102

Maternal Smoking 103

Maternal Alcohol Consumption 104

Low Birth Weight and ADHD 106

Trace Elements in ADHD 107

Food Additives, Allergies, and Responses 108

Fatty Acids in ADHD 109

Television and Computer Games 111

The Environment: Blame Culture, Agency, Free Will, Families, and Society 113

Summary 115

4 Neuropsychological Theories of ADHD 117

Executive Functions 117

Neuropsychological Tests and the Generation of Theories 118

Theory of Mind 122

Impulse Control: Impulsivity and Behavioral/Response Inhibition 125

Barkley's Neuropsychological Account - Behavioral Inhibition 127

Measures of Behavioral Inhibition and ADHD 129

Motivational Inhibition 138

Working Memory 138

Barkley's Updated Executive Functioning Model 143

Alerting, Orienting, and Executive Functioning - Separate Circuits in Adhd 144

The Supervisory Attentional System 146

Brown's Executive Functioning Model 147

Cognitive-Energetic Model 148

A Behavioral Neuroenergetics Theory of ADHD 149

Summary 151

5 The Genetics of ADHD 153

The Evidence for (and Against) ADHD as a Genetically Inherited Disorder 154

Behavioral Genetics 154

Twins 154

Evolutionary Explanations for ADHD and Its Continuation 158

Evolutionary Psychology, ADHD, and Specific Genes 162

Molecular Genetics 164

A Brief Lesson on Genetics 164

Genetic Variation 167

Polymorphisms 167

Variable Number Tandem Repeats 168

Genetic Markers 168

Epigenetics 168

Exploring Genes in ADHD 170

Dopamine Genes and ADHD 171

Dopamine Transporter Gene 171

DRD4 Gene 172

DRD1 Gene 173

DRD2 Gene 173

DRD3 Gene 173

DRD5 Gene 174

Other Non-DA or Non-DA Specific Related Genes 174

Catechol-O-Methyltransferase (COMT) Gene 174

SNAP25 Gene 175

TH (Tyrosine Hydroxylase), DOPA Decarboxylase, and DBH (Dopamine Beta-Hydroxylase) Genes 175

MAOA (Monoamine Oxidase A) Genes 176

BDNF (Brain-Derived Neurotrophic Factor) 176

Noradrenergic Genes 176

Serotonergic Genes 177

Is There a Gene for ADHD? 177

Admixture in the Genetics of ADHD 180

Can Genes Explain the Sex Difference in ADHD (If There Is a Difference)? 181

The Endophenotype 183

Summary 185

6 The Neuroscience of ADHD 187

The Brain: A Brief Guide to Development and Neuroanatomy 187

Developmental Changes in the Brain 188

Regions of the Brain 190

The Cortex 191

The Limbic System 191

The Basal Ganglia 191

Cerebellum 194

A Brief Account of Imaging the Brain 194

The Brain in ADHD 196

Structural Changes 196

Gray and White Matter 196

The Cortex 197

The Frontal Lobes 198

The Parietal Lobe 198

Basal Ganglia 198

Cerebellum 199

Functional Significance 200

Functional Imaging of ADHD 200

Psychophysiological Studies 201

Connectivity in ADHD 202

The Fronto-striatal Circuits 203

Fronto-parietal Circuits 205

Corticocerebellar Circuits 205

Default Mode Network and Task-Positive Networks in ADHD 205

Summary 208

7 Psychostimulant Medication for ADHD: From Treatment to Theory (and Back Again) 211

A Brief Review of the Neuropharmacology 211

Electrical Communication 212

Synaptic Transmission 214

Pharmacotherapy in ADHD 218

The Pharmacology and Efficacy of Psychostimulants used in treating ADHD 221

Methylphenidate 222

Pharmacology 222

Amphetamine 227

Pharmacology 227

Clinical Effects of Amphetamine and Methylphenidate 229

The MTA Study 232

Other Studies and Neurocognitive Processes 237

Side Effects and Concerns with Amphetamine and Methylphenidate 237

Other Drugs that Increase Dopamine Levels 240

L-Dopa 240

Apomorphine 241

Bromocriptine 241

Monoamine Oxidase Inhibitors 242

Pemoline 243

Pharmacology 243

Clinical Effects 243

Side Effects 243

Nicotine 244

Pharmacology 244

Clinical Effects 244

Tolerance and Withdrawal 245

Placebo Effects in ADHD 246

Psychopharmacology: From Treatment to Theory 248

Hypo/Hyperfunctioning DA in ADHD 249

Grace's Tonic and Phasic Account of ADHD 250

A Dynamic Developmental Theory of ADHD 252

The Rate-dependent Hypothesis and the Effects of Psychostimulants 253

Extending the Theory to Norepinephrine 255

Summary 255

8 Non-stimulant Medications and Non-pharmacological Treatments 257

Non-stimulant Medications 257

Atomoxetine 258

Viloxazine 262

Modafinil 262

Clonidine and Guanfacine 264

Centanafadine: A Mixed Dopamine, Norepinephrine, and Serotonin-Based Drug 266

How Do These Drugs Fit into Theoretical Accounts of ADHD? 266

Non-pharmacological Treatments 268

Neurotherapeutics 268

Neurofeedback 268

Brain Stimulation 270

Behavioral Therapies 272

Cognitive Behavioral Therapy (CBT) 273

Other Behavioral Therapies 276

Alternative Treatments 277

Summary 278

9 Addiction, Reward, and ADHD 279

Addiction 279

The Neuropsychopharmacology of Addiction 280

Addiction in ADHD 284

Are ADHD Symptoms Subtypes Linked to Any Specific Drugs? 286

Amphetamines, Methylphenidate, and Addiction 288

Methylphenidate Treatment and Addiction 290

Drugs, Cannabis, and Psychiatry 293

Psychedelics, Endocannabinoids, and CBD: A New Treatment Strand for ADHD? 294

Slow-Release Formulations and the Treatment of Cocaine and Amphetamine Addiction 295

Theories of ADHD Based on DA Reward Pathways 298

Methylphenidate and Long-term Neural Changes: Sensitization 298

Reward Deficiency in ADHD: Theory and Evidence 300

Reward Prediction Error 302

The Dopamine Transfer Deficit Hypothesis of ADHD 304

The Dual-Pathway Model of ADHD 305

Impulsivity in SUD and ADHD (Revisited) 308

Summary 309

10 The Past, Present, and Future Science of ADHD 311

Toward a Better Understanding and Treatment of ADHD 316

What Do the NICE Guidelines on ADHD Really State? 317

Glossary 321

References 337

Index 507

最近チェックした商品